Drug Profile
Research programme: retroviral integrase inhibitors - Serometrix
Alternative Names: Integrase Strand Transfer Inhibitors - Serometrix; SX-HIV1Latest Information Update: 28 Aug 2020
Price :
$50
*
At a glance
- Originator Serometrix
- Class Antivirals; Peptides
- Mechanism of Action HIV integrase inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
- New Molecular Entity Yes
- Available For Licensing Yes - HIV infections
Highest Development Phases
- No development reported HIV infections
Most Recent Events
- 28 Aug 2020 No recent reports of development identified for research development in HIV-infections in USA
- 12 Jul 2016 Research programme: retroviral integrase inhibitors - Serometrix is available for licensing as of 12 Jul 2016. http://www.serometrix.com/
- 12 Jul 2016 Early research in HIV infections in USA (unspecified route)